The U.S. health regulator has authorized COVID-19 shots from Moderna and Pfizer and its partner BioNTech that target both the original coronavirus and omicron subvariants for use in children as young as 6 months of age. The amended authorization on Thursday from the Food and…

Read Full Article (External Site)